Abstract
To establish a strategy for developing 111In- diethylenetriaminepentaacetic acid (111In-DTPA)-octreotide, a diagnostic radiopharmaceutical agent for tumors, with reduced non-specific renal radio-accumulation, the compounds having D-glutamic acid (Glu) or γ-carboxy-D-glutamic acid (carboxy-Glu) as the N-terminal amino acid were examined for in vivo radio-distribution. Compounds carrying Glu and carboxy-Glu containing one and two negative charges, respectively, showed lower renal radio-accumulation than that carrying D-phenylalanine. It was revealed that the introduction of a negative charge reduces the renal radio-accumulation independently from the number of negative charges. The present result can be a clue for the development of 111In-DTPA-octreotides with reduced the renal radio-accumulation.
| Original language | English |
|---|---|
| Pages (from-to) | 2226-2228 |
| Number of pages | 3 |
| Journal | Biological and Pharmaceutical Bulletin |
| Volume | 30 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - Nov 2007 |
| Externally published | Yes |
Keywords
- In-diethylenetriaminepentaacetic acid-octreotide
- Kidney
- Negative charge
- Radio-accumulation
ASJC Scopus subject areas
- Pharmacology
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Effect of carboxyl-group of D-glutamic acid or γ-carboxy-D-glutamic acid as N-terminal amino acid of 111In-diethylenetriaminepentaacetic acid-octreotide on accumulation of radioactivity in kidney'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS